Abstract
A 58-year-old white female presented to the Breast Care Center following an abnormal screening mammogram. Mammography revealed a suspicious 10 mm focus with calcifications of varying size and density in the upper-outer quadrant of the right breast. The patient complained of bilateral intermittent breast pain, but she had not noted any masses or nipple discharge. She had a benign left breast biopsy five years earlier but had no personal history of cancer. Her mother was diagnosed with breast cancer at the age of 65. Also, a maternal aunt and two maternal great-aunts were diagnosed with breast cancer while in their sixties. On physical examination, no discrete masses were palpated and no palpable lymph nodes were identified. The exam was also negative for skin changes and nipple discharge. The patient was referred for ultrasound guided biopsy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826
van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536
Dowsett M, Cuzick J, Wale C et al (2010) Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol 28:1829–1834
Paik S, Tang G, Shak S et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726–3734
Albain KS, Barlow WE, Shak S et al (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, Âoestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11:55–65
Habel LA, Shak S, Jacobs MK et al (2006) A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 8:R25
Baehner FL, Achacoso NS, Maddala T et al (2008) HER2 assessment in a large Kaiser Permanente case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. Paper presented at the ASCO breast cancer symposium abstracts, Washington, D.C. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=58&abstractID=40409. Accessed 10 June 2010
O’Connor SM, Beriwal S, Dabbs DJ et al (2010) Concordance between semiquantitative immunohistochemical assay and Oncotype DX RT-PCR assay for estrogen and progesterone receptors. Appl Immunohistochem Mol Morphol 18:268–272
Badve SS, Baehner FL, Gray RP et al (2008) Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 26:2473–2481
Mook S, Knauer M, Bueno-de-Mesquita JM et al (2010) Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature. Ann Surg Oncol 17:1406–1413
Buyse M, Loi S, van’t Veer LJ et al (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98:1183–1192
Wittner BS, Sgroi DC, Ryan PD et al (2008) Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res 14:2988–2993
van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast. N Engl J Med 347:1999–2009
Knauer M, Mook S, Rutgers EJ et al (2010) The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 120:655–661
Berg AO, Armstrong K, Botkin J et al (2009) RecommenÂdations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet Med 11:66–73
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Laudadio, J. (2011). Breast Cancer. In: Schrijver, I. (eds) Diagnostic Molecular Pathology in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19677-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-19677-5_21
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19676-8
Online ISBN: 978-3-642-19677-5
eBook Packages: MedicineMedicine (R0)